Clover announces positive clinical data for RSV Vaccine candidate SCB-1019 compared head-to-Head Versus GSK's AREXVY
October 29, 2024 | 05:32
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world..
Mobile Version